Results 101 to 110 of about 28,049 (192)

Risk for Human African Trypanosomiasis, Central Africa, 2000–2009

open access: yesEmerging Infectious Diseases, 2011
Comprehensive georeference records for human African trypanosomiasis in Cameroon, Central African Republic, Chad, Congo, Equatorial Guinea, and Gabon were combined with human population layers to estimate a kernel-smoothed relative risk function.
Pere P. Simarro   +8 more
doaj   +1 more source

African Trypanosomiasis [PDF]

open access: yes, 2020
Sanjeev Krishna   +2 more
  +6 more sources

Immunoprophylaxis Against African Trypanosomiasis

open access: yes, 1977
To put the subject matter of this chapter in its proper perspective, it should first be made clear that the development of a vaccine against trypanosomiasis of cattle and sheep is perhaps the last practical possibility which would occur to most people whose daily business is concerned with the control of trypanosomiasis in the field in Africa today ...
Murray, M., Urquhart, G.M.
openaire   +3 more sources

Molecular epidemiology of African trypanosomiasis: the contributions of David George Godfrey OBE to the biochemical characterization of trypanosomes*

open access: yesParasite, 2008
The accurate identification of the causative organisms of disease is fundamental to the study of epidemiology. Hence molecular tools are now widely used to detect and distinguish pathogens, and have greatly improved our understanding of epidemiology ...
Gibson W.
doaj   +1 more source

Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T. b. gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa

open access: yesBulletin of the World Health Organization, 2002
OBJECTIVE: To evaluate the performance of serological tests using dried blood on filter-papers (micro-card agglutination test for trypanosomiasis (micro-CATT)) performed under field and laboratory conditions and using whole blood ((CATT/T.b.
Truc Philippe   +7 more
doaj  

A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.

open access: yesPLoS Neglected Tropical Diseases, 2016
Humans are protected against infection from most African trypanosomes by lipoprotein complexes present in serum that contain the trypanolytic pore-forming protein, Apolipoprotein L1 (APOL1).
Anneli Cooper   +7 more
doaj   +1 more source

Benefit-Cost Analysis and Socio-Economic Considerations of Trypanosomiasis Control and Treatment in Northern Ghana [PDF]

open access: yes
The paper estimates the cost of tsetse control and treatment of trypanosomiasis and the benefits involved, using benefit-cost analysis. It also estimates the extent to which socio-economic characteristics of farmers affect the use of tsetse control ...
Asuming-Brempong, Samuel, Wahab, S.
core   +1 more source

Africa and the Cattle Without History

open access: yesGlobal Environment
African historiography of tsetse-borne trypanosomiasis has yet to fully embrace the genetic basis of cattle tolerance to the disease due to the literature’s emphasis on human illness and landscape modification.
Tad Brown
doaj   +1 more source

Epidemiology of human African trypanosomiasis

open access: yesClinical Epidemiology, 2014
Jose R Franco,1 Pere P Simarro,1 Abdoulaye Diarra,2 Jean G Jannin1 1World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland; 2World Health Organization, Inter Country Support ...
Franco JR   +3 more
doaj  

Home - About - Disclaimer - Privacy